SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Operating Lease, Liability, Noncurrent
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Operating Lease, Liability, Noncurrent of $112.35 thousand as of 2026-06-30, per its 10-Q filed 2026-09-24.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-09-24
- 2026-06-30: Operating Lease, Liability, Noncurrent $112.35K.
- 2026-03-31: Operating Lease, Liability, Noncurrent $134.05K.
- 2025-12-31: Operating Lease, Liability, Noncurrent $154.95K.
- 2025-09-30: Operating Lease, Liability, Noncurrent $175.32K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $112.35K 10-Q · filed 2026-09-24 |
| 2026-03-31 | $134.05K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $154.95K 10-Q · filed 2026-09-24 |
| 2025-09-30 | $175.32K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $195.16K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $220.11K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $238.09K 10-K · filed 2026-03-31 |
| 2024-09-30 | $255.60K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $267.02K 10-Q · filed 2024-09-04 |
| 2024-03-31 | $288.60K 10-Q/A · filed 2024-09-04 |
| 2023-12-31 | $304.13K 10-K · filed 2025-02-26 |
| 2023-09-30 | $308.43K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $329.77K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $751.69K 10-Q · filed 2023-05-25 |
| 2022-09-30 | $6.67K 10-Q · filed 2022-11-14 |
| 2021-12-31 | $62.44K 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |